Improving Seizure Frequency Documentation and Classification.


Journal

Neurology. Clinical practice
ISSN: 2163-0402
Titre abrégé: Neurol Clin Pract
Pays: United States
ID NLM: 101577149

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 07 04 2023
accepted: 01 09 2023
pmc-release: 01 12 2024
medline: 24 10 2023
pubmed: 24 10 2023
entrez: 24 10 2023
Statut: ppublish

Résumé

Accurate and reliable seizure data are essential for evaluating treatment strategies and tracking the quality of care in epilepsy clinics. This quality improvement project aimed to increase seizure documentation (i.e., documentation of seizure frequency from 80% to 100%, date of last seizure from 35% to 50%, and International League Against Epilepsy (ILAE) seizure classification from 35% to at least 50%) over 6 months. We surveyed 7 epileptologists to determine their perceived seizure frequency, ILAE classification, and date of last seizure documentation habits. Baseline data were collected weekly from September to December 2021. Subsequently, we implemented a newly created flowsheet in our Electronic Health Record (EHR) based on the Epilepsy Learning Healthcare System (ELHS) Case Report Forms to increase seizure documentation in a standardized way. Two epileptologists tested this flowsheet tool in their epilepsy clinics between February 2022 and July 2022. Data were collected weekly and compared with documentation from other epileptologists within the same group. Epileptologists at our center believed they documented seizure frequency for 84%-87% of clinic visits, which aligned with baseline data collection, showing they recorded seizure frequency for 83% of clinic visits. Epileptologists believed they documented ILAE classification for 47%-52% of clinic visits, and baseline data showed this was documented in 33% of clinic visits. They also reported documenting the date of the last seizure for 52%-63% of clinic visits, but this occurred in only 35% of clinic visits. After implementing the new flowsheet, documentation increased to nearly 100% for all fields being completed by the providers who tested the flowsheet. We demonstrated that by implementing an easy-to-use standardized EHR documentation tool, our documentation of critical metrics, as defined by the ELHS, improved dramatically. This shows that simple and practical interventions can substantially improve clinically meaningful documentation.

Sections du résumé

Background and Objectives UNASSIGNED
Accurate and reliable seizure data are essential for evaluating treatment strategies and tracking the quality of care in epilepsy clinics. This quality improvement project aimed to increase seizure documentation (i.e., documentation of seizure frequency from 80% to 100%, date of last seizure from 35% to 50%, and International League Against Epilepsy (ILAE) seizure classification from 35% to at least 50%) over 6 months.
Methods UNASSIGNED
We surveyed 7 epileptologists to determine their perceived seizure frequency, ILAE classification, and date of last seizure documentation habits. Baseline data were collected weekly from September to December 2021. Subsequently, we implemented a newly created flowsheet in our Electronic Health Record (EHR) based on the Epilepsy Learning Healthcare System (ELHS) Case Report Forms to increase seizure documentation in a standardized way. Two epileptologists tested this flowsheet tool in their epilepsy clinics between February 2022 and July 2022. Data were collected weekly and compared with documentation from other epileptologists within the same group.
Results UNASSIGNED
Epileptologists at our center believed they documented seizure frequency for 84%-87% of clinic visits, which aligned with baseline data collection, showing they recorded seizure frequency for 83% of clinic visits. Epileptologists believed they documented ILAE classification for 47%-52% of clinic visits, and baseline data showed this was documented in 33% of clinic visits. They also reported documenting the date of the last seizure for 52%-63% of clinic visits, but this occurred in only 35% of clinic visits. After implementing the new flowsheet, documentation increased to nearly 100% for all fields being completed by the providers who tested the flowsheet.
Discussion UNASSIGNED
We demonstrated that by implementing an easy-to-use standardized EHR documentation tool, our documentation of critical metrics, as defined by the ELHS, improved dramatically. This shows that simple and practical interventions can substantially improve clinically meaningful documentation.

Identifiants

pubmed: 37873534
doi: 10.1212/CPJ.0000000000200212
pii: CPJ-2023-000175
pmc: PMC10586801
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e200212

Informations de copyright

© 2023 American Academy of Neurology.

Déclaration de conflit d'intérêts

P. Nuthalapati, M.A. Donahue, S. DeStefano: have no conflict of interest to disclose. L.M.V.R.M.: support from the Centers for Diseases Control and Prevention (U48DP006377), the NIH (NIH-NIA 5K08AG053380-02, NIH-NIA 5R01AG062282-02, NIH-NIA 2P01AG032952-11, NIH- NIA 3R01AG062282-03S1), and the Epilepsy Foundation of America and reports no conflict of interest. J. Pellinen has no conflicts of interest directly related to this work. In the past 2 years, he has received research support from the Department of Neurology at the University of Colorado School of Medicine, the Colorado Clinical and Translational Sciences Institute by way of NIH/NCATS Colorado CTSA Grant Number UL1 TR002535, the NIH/NINDS in the form of a Clinical Research LRP, and from the American Epilepsy Society. He serves as chair of the professional advisory board for the Epilepsy Foundation of Colorado and Wyoming (unpaid), serves as the Epilepsy Section Editor for Current Neurology and Neuroscience Reports, and has received salary support for advisory board work for SK Life Science. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Références

JAMA. 2013 Jun 5;309(21):2215-6
pubmed: 23736730
Neurology. 2018 Oct 30;91(18):829-836
pubmed: 30282773
Neurol Clin Pract. 2019 Feb;9(1):83-88
pubmed: 30859011
Pediatrics. 2017 Sep;140(3):
pubmed: 28814576
Nat Rev Neurol. 2011 Apr;7(4):195-6
pubmed: 21468102
Nat Rev Neurol. 2017 Jun;13(6):324-325
pubmed: 28474683
Epilepsia. 2019 Jan;60(1):175-183
pubmed: 30585315
Neurology. 2020 Jul 14;95(2):e213-e223
pubmed: 32546650
Am J Med Qual. 2009 Sep-Oct;24(5):385-94
pubmed: 19482968
Neurol Clin Pract. 2019 Aug;9(4):360-364
pubmed: 31583192
Stat Biosci. 2016 Jun;8(1):159-180
pubmed: 27617041
Epilepsia. 2017 Jan;58(1):68-76
pubmed: 27864833
J Pain Symptom Manage. 2016 Jul;52(1):1-7
pubmed: 27241439
BMJ Qual Saf. 2016 Dec;25(12):986-992
pubmed: 26369893
JAMA Netw Open. 2019 Apr 5;2(4):e191709
pubmed: 30951160
J Oncol Pract. 2019 Nov;15(11):e989-e996
pubmed: 31225981
Sci Rep. 2017 Apr 07;7:46226
pubmed: 28387314
Epilepsy Behav. 2012 Aug;24(4):468-73
pubmed: 22770880
Pediatr Qual Saf. 2018 Sep 20;3(5):e103
pubmed: 30584630
Neurology. 2011 Jan 4;76(1):94-9
pubmed: 21205698
Inflamm Bowel Dis. 2011 Jan;17(1):450-7
pubmed: 20602466
Neurology. 2016 Dec 6;87(23):2435-2442
pubmed: 27815405
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Epilepsy Behav. 2016 Sep;62:90-6
pubmed: 27450312
BMC Neurol. 2013 Aug 28;13:112
pubmed: 23984949
Seizure. 2013 Oct;22(8):604-10
pubmed: 23537634
BMJ Qual Improv Rep. 2016 Aug 31;5(1):
pubmed: 27651897
Neurology. 2011 Jan 4;76(1):23-7
pubmed: 21205691
Neurol Clin Pract. 2017 Apr;7(2):109-117
pubmed: 28409062
Mayo Clin Proc. 2016 Jul;91(7):836-48
pubmed: 27313121
Epilepsia. 2017 Apr;58(4):531-542
pubmed: 28276064
Epilepsy Behav. 2021 Apr;117:107805
pubmed: 33588319
J Biomed Inform. 2018 Jan;77:34-49
pubmed: 29162496

Auteurs

Poojith Nuthalapati (P)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Lionel Thomas (L)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Maria A Donahue (MA)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Lidia M V R Moura (LMVR)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Samuel DeStefano (S)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Jennifer R Simpson (JR)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Jeffrey Buchhalter (J)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Brandy E Fureman (BE)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Jacob Pellinen (J)

Department of Neurology (PN, MAD, LMVRM), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (LT, SD, JRS, JP), University of Colorado School of Medicine, Aurora; Department of Pediatrics (JB), Cumming School of Medicine, University of Calgary, AB, CA; and Mission Outcomes Team (BEF), Epilepsy Foundation, Landover, MD.

Classifications MeSH